132 related articles for article (PubMed ID: 37858609)
21. A Novel Combinatorial Epigenetic Therapy Using Resveratrol and Pterostilbene for Restoring Estrogen Receptor-α (ERα) Expression in ERα-Negative Breast Cancer Cells.
Kala R; Tollefsbol TO
PLoS One; 2016; 11(5):e0155057. PubMed ID: 27159275
[TBL] [Abstract][Full Text] [Related]
22. Estradiol-independent modulation of breast cancer transcript profile by 17beta-hydroxysteroid dehydrogenase type 1.
Aka JA; Calvo EL; Lin SX
Mol Cell Endocrinol; 2017 Jan; 439():175-186. PubMed ID: 27544780
[TBL] [Abstract][Full Text] [Related]
23. Estrogen down regulates COMT transcription via promoter DNA methylation in human breast cancer cells.
Wu Q; Odwin-Dacosta S; Cao S; Yager JD; Tang WY
Toxicol Appl Pharmacol; 2019 Mar; 367():12-22. PubMed ID: 30684530
[TBL] [Abstract][Full Text] [Related]
24. Redox signalling to nuclear regulatory proteins by reactive oxygen species contributes to oestrogen-induced growth of breast cancer cells.
Okoh VO; Garba NA; Penney RB; Das J; Deoraj A; Singh KP; Sarkar S; Felty Q; Yoo C; Jackson RM; Roy D
Br J Cancer; 2015 May; 112(10):1687-702. PubMed ID: 25965299
[TBL] [Abstract][Full Text] [Related]
25. Eliminating epigenetic barriers induces transient hormone-regulated gene expression in estrogen receptor negative breast cancer cells.
Fleury L; Gerus M; Lavigne AC; Richard-Foy H; Bystricky K
Oncogene; 2008 Jul; 27(29):4075-85. PubMed ID: 18317449
[TBL] [Abstract][Full Text] [Related]
26. Histone H3 lysine 4 acetylation and methylation dynamics define breast cancer subtypes.
Messier TL; Gordon JA; Boyd JR; Tye CE; Browne G; Stein JL; Lian JB; Stein GS
Oncotarget; 2016 Feb; 7(5):5094-109. PubMed ID: 26783963
[TBL] [Abstract][Full Text] [Related]
27. Epigenetic profiling of multidrug-resistant human MCF-7 breast adenocarcinoma cells reveals novel hyper- and hypomethylated targets.
Chekhun VF; Lukyanova NY; Kovalchuk O; Tryndyak VP; Pogribny IP
Mol Cancer Ther; 2007 Mar; 6(3):1089-98. PubMed ID: 17363502
[TBL] [Abstract][Full Text] [Related]
28. Nicotine-induced oxidative stress contributes to EMT and stemness during neoplastic transformation through epigenetic modifications in human kidney epithelial cells.
Chang YW; Singh KP
Toxicol Appl Pharmacol; 2019 Jul; 374():65-76. PubMed ID: 31047982
[TBL] [Abstract][Full Text] [Related]
29. Histone lysine trimethylation or acetylation can be modulated by phytoestrogen, estrogen or anti-HDAC in breast cancer cell lines.
Dagdemir A; Durif J; Ngollo M; Bignon YJ; Bernard-Gallon D
Epigenomics; 2013 Feb; 5(1):51-63. PubMed ID: 23414320
[TBL] [Abstract][Full Text] [Related]
30. Estrogenic actions of RU486 in hormone-responsive MCF-7 human breast cancer cells.
Jeng MH; Langan-Fahey SM; Jordan VC
Endocrinology; 1993 Jun; 132(6):2622-30. PubMed ID: 8504763
[TBL] [Abstract][Full Text] [Related]
31. Nuclear-encoded mitochondrial MTO1 and MRPL41 are regulated in an opposite epigenetic mode based on estrogen receptor status in breast cancer.
Kim TW; Kim B; Kim JH; Kang S; Park SB; Jeong G; Kang HS; Kim SJ
BMC Cancer; 2013 Oct; 13():502. PubMed ID: 24160266
[TBL] [Abstract][Full Text] [Related]
32. Chronic oxidative stress increases growth and tumorigenic potential of MCF-7 breast cancer cells.
Mahalingaiah PK; Singh KP
PLoS One; 2014; 9(1):e87371. PubMed ID: 24489904
[TBL] [Abstract][Full Text] [Related]
33. Estrogenic activity of a dieldrin/toxaphene mixture in the mouse uterus, MCF-7 human breast cancer cells, and yeast-based estrogen receptor assays: no apparent synergism.
Ramamoorthy K; Wang F; Chen IC; Norris JD; McDonnell DP; Leonard LS; Gaido KW; Bocchinfuso WP; Korach KS; Safe S
Endocrinology; 1997 Apr; 138(4):1520-7. PubMed ID: 9075711
[TBL] [Abstract][Full Text] [Related]
34. Epigenetic silencing of genes enhanced by collective role of reactive oxygen species and MAPK signaling downstream ERK/Snail axis: Ectopic application of hydrogen peroxide repress CDH1 gene by enhanced DNA methyltransferase activity in human breast cancer.
Pradhan N; Parbin S; Kar S; Das L; Kirtana R; Suma Seshadri G; Sengupta D; Deb M; Kausar C; Patra SK
Biochim Biophys Acta Mol Basis Dis; 2019 Jun; 1865(6):1651-1665. PubMed ID: 30954555
[TBL] [Abstract][Full Text] [Related]
35. Estrogen Receptor-β Modulation of the ERα-p53 Loop Regulating Gene Expression, Proliferation, and Apoptosis in Breast Cancer.
Lu W; Katzenellenbogen BS
Horm Cancer; 2017 Aug; 8(4):230-242. PubMed ID: 28577282
[TBL] [Abstract][Full Text] [Related]
36. Persistently altered epigenetic marks in the mouse uterus after neonatal estrogen exposure.
Jefferson WN; Chevalier DM; Phelps JY; Cantor AM; Padilla-Banks E; Newbold RR; Archer TK; Kinyamu HK; Williams CJ
Mol Endocrinol; 2013 Oct; 27(10):1666-77. PubMed ID: 24002655
[TBL] [Abstract][Full Text] [Related]
37. A hidden Markov model to identify combinatorial epigenetic regulation patterns for estrogen receptor α target genes.
Bonneville R; Jin VX
Bioinformatics; 2013 Jan; 29(1):22-8. PubMed ID: 23104890
[TBL] [Abstract][Full Text] [Related]
38. Physical interaction of estrogen receptor with MnSOD: implication in mitochondrial O
Lone MU; Baghel KS; Kanchan RK; Shrivastava R; Malik SA; Tewari BN; Tripathi C; Negi MP; Garg VK; Sharma M; Bhatt ML; Bhadauria S
Oncogene; 2017 Mar; 36(13):1829-1839. PubMed ID: 27721400
[TBL] [Abstract][Full Text] [Related]
39. Effects of pharmacological concentrations of estrogens on proliferation and cell cycle kinetics of human breast cancer cell lines in vitro.
Reddel RR; Sutherland RL
Cancer Res; 1987 Oct; 47(20):5323-9. PubMed ID: 3652038
[TBL] [Abstract][Full Text] [Related]
40. Interplay of ERα binding and DNA methylation in the intron-2 determines the expression and estrogen regulation of cystatin A in breast cancer cells.
John Mary DJS; Sikarwar G; Kumar A; Limaye AM
Mol Cell Endocrinol; 2020 Mar; 504():110701. PubMed ID: 31926189
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
